The return to Trump's tariff war put a pin in an already wobbly week for markets, which were pulled in different directions ...
Novo Nordisk has cut its cell therapy division, where it was trying to find a cure for type 1 diabetes, Bloomberg News ...
Markets have had an uncertain week, pulled in different directions by AI demand hopes and US government shutdown worries.
Wall Street is looking to U. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...
() -Johnson & Johnson is in discussions to buy Protagonist Therapeutics, a source familiar with the matter told . Shares of ...
OTTAWA (Reuters) -Reviving the proposed Keystone XL oil pipeline from Alberta to the U.S. could play a part in tightening U.S ...
Delta Air Lines and Aeromexico sued the U. government challenging an order that they unwind a joint venture by January 1 that ...
US stocks (^DJI, ^IXIC, ^GSPC) are spiraling on Friday after President Trump threatened China with a tariff hike; the Nasdaq ...
The U.S. Bureau of Labor Statistics said on Friday it would publish September's consumer inflation report on October 24 to ...
A monthslong calm on Wall Street is shattering Friday, and U.S. stocks are falling after President Donald Trump threatened to ...
You could be forgiven for having never heard about this Aussie upstart. But it is quickly blazing a path to the top of the ...
The IRS has announced several updates that will impact how Americans file their taxes over the next two years.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results